Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration

Leukemia and Lymphoma

Volumn 30, Issue 3-4, 1998, Pages 293-306

  Beck, Zoltán ^a   Bácsi, Attila ^a   Kovács, Eszter ^a   Kiss, Jolán ^a   Kiss, Attila ^a   Balogh, Erzsébet ^a   Telek, Béla ^a   Tóth, Ferenc D ^a   Andirkó, István ^a   Oláh, Éva ^a   Udvardy, Miklós ^a   Rak, Kalman ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

bce abl; c myb; CGL acceleration oncogenes cytogenetics; Chronic granulocytic leukemia; H ras transcripts

Indexed keywords

BCR ABL PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC GRANULOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MALE; ONCOGENE; ONCOGENE C MYB; ONCOGENE C MYC; ONCOGENE H RAS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 7344233693     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057542     Document Type: Article

References (50)

1. Dickstein, J. I. and Vardiman, J. W. (1993). Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and myelodysplastic syndromes. Am. J. Clin. Pathol., 99, 513-525.
2. Kantarjian, H. M., Talpaz, M. and Gutterman, J. U. (1988). Chronic myelogenous leukemia: Past, present and future. Hematol. Pathol., 2, 91-120.
3. Sokal, J. E., Baccarani, M., Russo, D. and Tura, S. (1988). Staging and prognosis in chronic myelogenous leukemia. Semin. Hematol., 25, 49-61.
4. Nowell, P. C. and Hungerford, D. A. (1960). A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497-1498.
5. Rowley, J. D. (1973). A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 290-295.
6. Heisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. and Grosveld, G. (1983). Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature, 306, 239-242.
7. Shtivelman, E., Lifshitz, B., Gale, R. P. and Canaani, E. (1985). Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature, 315, 550-554.
8. Konopka, J. B., Watanabe, S. M. and Witte, O. N. (1984). An alteration of human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 37, 1035-1039.
9. Cervantes, F., Ballesta, F., Milá, M. and Rozman, C. (1986). Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: results and prognostic evaluation in 52 patients. Cancer Genet. Cytogenet., 21, 239-246.
10. Liu, E., Hjelle, B. and Bishop, J. M. (1988). Transforming genes in chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA, 85, 1952-1956.
11. LeMaistre, A., Lee, M. S., Talpaz, M., Kantarjian, H. M., Freireich, E. J., Deisseroth, A. B., Trujillo, J. M. and Stass, S. A. (1989). RAS oncogene mutations are rare late stage events in chronic myelogenous leukemia. Blood, 73, 889-891.
12. Ahuja, H., Bar-Eli, M., Arlin, Z., Advani, S., Allen, S. L., Goldman, J., Snyder, D., Foti, A. and Cline, M. (1991). The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest., 87, 2042-2047.
13. McCarthy, D. M., Goldman, J. M., Rasool, F. V., Graham, S. V. and Birnie, G. D. (1984). Genomic alterations involving the c-myc proto-oncogene during the evolution of chronic granulocytic leukemia. Lancet, 2, 1362-1365.
14. Hjorth, R., Jonsson, A. K. and Vretblad, P. (1981). A rapid method for purification of human granulocytes using Percoll. A comparison with dextran sedimentation. J. Immun. Meth., 43, 95-101.
15. Collins, S. J. and Groudine, M. T. (1983). Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc. Natl. Acad. Sci. USA, 80, 4813-4817.
16. Collins, S. J., Kubonishi, I., Miyoshi, I. and Groudine, M. T. (1984). Altered transcription of the c-abl oncogene in K562 and other chronic myelogenous leukemia cells. Science, 225, 72-74.
17. Dalla-Favera, R., Wong-Staal, F. and Gallo, R. C. (1982). one gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature, 299, 61-63.
18. Westin, E. H., Wong-Staal, F., Gelman, E. P., Dalla-Favera, R., Papas, T. S., Lautenberger, J. A., Eva, A., Reddy, E. P., Tronick, S. R., Aaronson, S. A. and Gallo, R. C. (1982). Expression of cellular homologues of retroviral one genes in human hematopoietic cells. Proc. Natl. Acad. Sci. USA, 79, 2490-2494.
19. Westin, E. H., Gallo, R. C., Arya, S. K., Eva, A., Souza, L. M., Baluda, M. A., Aaronson, S. A. and Wong-Staal, F. (1982). Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Sci. USA, 79, 2194-2198.
20. Kurzrock, R., Kantarjian, H. M., Shtalrid, M., Gutterman, J. U. and Talpaz, M. (1990). Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course. Blood, 75, 445-452.
21. Majello, B., Kenyon, L. C. and Dalla-Favera, R. (1986). Human c-myb proto-oncogene: nucleotide sequence of cDNA and organization of the genomic locus. Proc. Natl. Acad. Sci. USA, 83, 9636-9640.
22. Kelly, R. G., Cozzarelli, N., Deutscher, M. P., Lehman, I. R. and Kornberg, A. (1970). Enzymatic synthesis of deoxyribonucleic acid. J. Biol. Chem., 245, 39-45.
23. White, B. A. and Bancroft, F. C. (1982). Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J. Biol. Chem., 257, 8569-8572.
24. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. and Rutter, W. J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299.
25. Thomas, P. S. (1980). Hybridization of denaturated RNA and smaller DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA, 77, 5201-5205.
26. Kafatos, F., Jones, C. and Efstratiadis. A. (1979). Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucl. Acids Res., 7, 1541-1552.
27. Seabright, M. (1971). A rapid banding technique for human chromosomes. Lancet, 2, 971-972.
28. Casperson, T., Zeich, L. and Johansson, C. (1970). Differential binding of alkylating fluorochromes in human chromosomes. Exp. Cell Res., 60, 315-319.
29. International Society for Cytogenetic Nomenclature (ISCN) (1978). An international system for human cytogenetic nomenclature. Cytogenet. Cell Genet., 21, 309-404.
30. bcr/abl: Implication for RAS-dependent Philadelphia chromosome positive cell growth. J. Exp. Med., 179, 1855-1865.
31. Slamon, D. J., deKernion, J. B., Verma, I. M. and Cline, M. J. (1984). Expression of cellular oncogenes in human malignancies. Science, 224, 256-262.
32. McGahon, A., Bissonette, R., Schmitt, M., Cotter, K. M., Green, D. R. and Cotter, T. G. (1994). BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179-1187.
33. Donner, P., Greiser-Wilke, I. and Moelling, K. (1982). Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature, 296, 262-265
34. Evan, G. L., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z. and Hancock, D. C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
35. Romero, P., Blick, M., Talpaz, M., Murphy, E., Hester, J. and Gutterman, J. (1986). C-sis and c-abl expression in chronic myelogenous leukemia and other hematologic malignancies. Bllood, 67, 839-841.
36. Dainiak, N., Davies, G., Kalmanti, M., Lawler, J. and Kulkarni, V. (1983). Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro. J. Clin. Invest., 71, 1206-1214.
37. Collins, S. J. and Groudine, M. T. (1987). Chronic myelogenous leukemia: Amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis. Blood, 69, 893-898.
38. Blick, M., Romero, P., Talpaz, M., Kurzrock, R., Shtalrid, M., Andersson, B., Trujillo, J., Beran, M. and Gutterman, J. (1987). Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet. Cytogenet., 27, 349-356.
39. Rothberg, P. G., Erisman, M. D., Diehl, R. E., Rovigatti, U. G. and Astrin, S. M. (1984). Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Mol. Cell. Biol., 4, 1096-1103.
40. Ahuja, H. G., Foti, A., Bar-Eli, M. and Cline, M. (1990). The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood, 75, 1684-1690.
41. Padau, R. A., Carter, G., Hughes, D., Gow, J., Farr, C., Oscier, D., McCormick, F. and Jacobs, A. (1988). RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization and transformation. Leukemia, 2, 503-510.
42. Stephenson, J., Mufti, G. J. and Yoshida, Y. (1993). Myelodysplastic syndromes: from morphology to molecular biology. Part II. The molecular genetics of myelodysplasia. Int. J. Hematol., 57, 99-112.
43. Isobe, M., Emanuel, B. S., Givol, D., Oren, M. and Croce, C. M. (1986). Localization of gene for human p53 tumor antigen to band 17p13. Nature, 320, 84-86.
44. Mori, N., Wada, M., Yokota, J., Terada, M., Okada, M., Tesamura, M., Masuda, M., Hushino, S., Motoji, T., Oshimi, K. and Muzoguchi, M. (1992). Mutations of the p53 suppressor gene in haematologic neoplasms. Br. J. Haematol., 81, 235-240.
45. Cline, M. J., Jat, P. S. and Foti, A. (1992). Molecular mechanisms in the evolution of chronic myelocytic leukaemia. Leuk. Lymph., 7, 283-286.
46. Yunis, J. J. and Ramsay, N. (1978). Retinoblastoma and subband deletion of chromosome 13. Am. J. Dis. Child., 132, 161-165.
47. Kantarjian, H. M., Keating, M. J., Walters, R. S., McCredie, K. B., Smith, T. L., Talpaz, M., Beran, M., Cork, A., Trujillo, J. M. and Feireich, E. J. (1986). Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia. Cancer, 58, 2023-2030.
48. LeBeau, M. M. (1992). Deletions of chromosome 5 in malignant myeloid disorders. Cancer Surv., 15, 143-159.
49. Bernstein, R. (1988). Cytogenetics of chronic myelogenous leukemia. Semin. Hematol., 25, 20-34.
50. Nowell, P. (1976). The clonal evolution of tumor cell populations. Science, 194, 23-28.